Brokerages Set DENTSPLY SIRONA Inc. (NASDAQ:XRAY) PT at $35.89

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Free Report) have received a consensus recommendation of “Moderate Buy” from the eleven brokerages that are presently covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $35.22.

A number of research firms recently weighed in on XRAY. Robert W. Baird lowered their price target on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating for the company in a report on Friday, May 3rd. Barrington Research reduced their price target on DENTSPLY SIRONA from $41.00 to $38.00 and set an “outperform” rating for the company in a report on Friday, May 3rd. Piper Sandler restated a “neutral” rating and set a $32.00 price objective (down from $35.00) on shares of DENTSPLY SIRONA in a report on Friday, May 3rd. Evercore ISI reduced their target price on DENTSPLY SIRONA from $40.00 to $35.00 and set an “outperform” rating for the company in a research note on Friday, May 3rd. Finally, SVB Leerink assumed coverage on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. They issued an “outperform” rating and a $42.00 target price for the company.

Get Our Latest Research Report on DENTSPLY SIRONA

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock opened at $28.25 on Friday. DENTSPLY SIRONA has a twelve month low of $26.27 and a twelve month high of $41.65. The stock has a market cap of $5.87 billion, a price-to-earnings ratio of -64.20, a price-to-earnings-growth ratio of 1.24 and a beta of 1.00. The company has a current ratio of 1.43, a quick ratio of 0.97 and a debt-to-equity ratio of 0.54. The company has a fifty day moving average price of $31.91 and a 200 day moving average price of $32.66.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last posted its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.42. The business had revenue of $953.00 million during the quarter, compared to analyst estimates of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The company’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same quarter last year, the firm earned $0.39 earnings per share. Equities research analysts forecast that DENTSPLY SIRONA will post 2.04 earnings per share for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were issued a dividend of $0.16 per share. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. The ex-dividend date of this dividend was Wednesday, March 27th. This represents a $0.64 annualized dividend and a dividend yield of 2.27%. DENTSPLY SIRONA’s payout ratio is -145.45%.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several large investors have recently made changes to their positions in XRAY. VisionPoint Advisory Group LLC grew its holdings in DENTSPLY SIRONA by 104.2% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after buying an additional 395 shares in the last quarter. Principal Securities Inc. acquired a new position in DENTSPLY SIRONA during the 4th quarter worth $26,000. Headlands Technologies LLC bought a new position in shares of DENTSPLY SIRONA in the fourth quarter worth $30,000. Parkside Financial Bank & Trust raised its stake in shares of DENTSPLY SIRONA by 33.3% during the fourth quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock valued at $42,000 after purchasing an additional 292 shares in the last quarter. Finally, Anchor Investment Management LLC bought a new position in DENTSPLY SIRONA in the 4th quarter valued at about $47,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

About DENTSPLY SIRONA

(Get Free Report

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Articles

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.